EGFR

Peng Li1, Qiufeng Jin1, Mingwei Su1

  • 1Department of Head Neck and Thyroid, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.

Frontiers in immunology
|December 8, 2025
PubMed
概括

新辅助免疫化学疗法 (NAIC) 显著改善了口腔状细胞癌 (OSCC) 患者的病理完整反应和生存率. 这种方法在局部先进的OSCC中提供了优异的结果,与其他新辅助治疗相比.